VivoSeq
Other

Cesarean Delivery

1

Pipeline Programs

15

Active Trials

2

Companies Involved

Cesarean Delivery is an early-stage landscape with 1 program across 2 companies. The most active players are Amring, BioQ Pharma, Inc..

Pipeline Metrics

Competitive Density

34/100

Pipeline Velocity

25/100

Mech. Concentration

100/100

Completion Rate

91/100

Attrition Rate

7/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Programs by Phase

Preclinical
No programs
Phase 2
No programs
Phase 3
No programs
Approved
No programs

Trial Status

118

clinical trials

Completed79 · 67%
Unknown status16 · 14%
Recruiting11 · 9%
Withdrawn5 · 4%
Terminated3 · 3%
Not yet recruiting2 · 2%
Other2 · 2%

Trial Activity

118 trials

Page 1 of 8

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)